#Alpha Emitter Market outlook

[janetushar1]

Alpha Emitter Market to Hit $1751.5 Million by 2032

The global Alpha Emitter Market was valued at USD 671.2 Million in 2024 and it is estimated to garner USD 1751.5 Million by 2032 with a registered CAGR of 11.25% during the forecast period 2024 to 2032.

Are you looking for the Alpha Emitter Market Research Report? You are at the right place. If you desire to find out more data about the report or want customization, Contact us. If you want any unique requirements, please allow us to customize and we will offer you the report as you want.

The global Alpha Emitter Market can be segmented on the basis of product type, Applications, distribution channel, market value, volume, and region [North America, Europe, Asia Pacific, Latin America, Middle East, and Africa]. The Alpha Emitter Industry 2024 report provides a comprehensive overview of critical elements of the industry including drivers, restraints, and management scenarios.

Download Sample PDF: @ https://www.vantagemarketresearch.com/alpha-emitter-market-2419/request-sample

Top Players

Actinium Pharmaceutical Inc., Alpha Tau Medical Ltd, Bayer AG, Bracco, Cardinal Health, Eckert & Ziegle, Fusion Pharmaceuticals, IBA Worldwide, NorthStar Medical Radioisotopes (NMR), Orano Group, Viewpoint Molecular Targeting, RadioMedix, Telix Pharmaceuticals Limited

Trending 2024: Alpha Emitter Market Report Highlights:

A comprehensive assessment of the parent Industry

Development of key aspects of the business

A study of industry-wide market segments

Evaluation of market value and volume in past, present, and future years

Evaluation of market share

Tactical approaches of market leaders

Innovative strategies that help companies to improve their position in the market

You Can Buy This Report From Here: https://www.vantagemarketresearch.com/buy-now/alpha-emitter-market-2419/0

Analysis Of The Top Companies, Product Types, and Applications In The Market Report:

This report provides sales, revenue growth rate, and verified information about the major players. Also includes a regional analysis and a labor cost analysis, tables, and figures. It also highlights characteristics such as technological growth. The product type segment is expected to continue to maintain its leading position in the future and capture a significant market share based on sales. This report provides analysis, discussion, forecast, and debate on key industry trends, market share estimates, Industry size, and other information. This report also discusses drivers, risks, and opportunities.

Global Alpha Emitter Market report contains detailed data and analysis on the Alpha Emitter Market drivers, restraints, and opportunities. Experts with market and industry knowledge as well as research experience from regional experts validate the report. The Alpha Emitter Market report provides forecast, historical and current revenue for each industry, region, and end-user segment.

Regions Included

-North America [United States, Canada, Mexico]

-South America [Brazil, Argentina, Columbia, Chile, Peru]

-Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]

-Middle East & Africa [GCC, North Africa, South Africa]

-Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]

Global Alpha Emitter Market report data will help you make more informed decisions. For example, in relation to prices, distribution channels are means of marketing or identifying opportunities to introduce a new product or service. These results will also help you make more informed decisions about your existing operations and activities.

Read Full Research Report with [TOC] @ https://www.vantagemarketresearch.com/industry-report/alpha-emitter-market-2419

You Can Use The Alpha Emitter Market Report To Answer The Following Questions:

What are the growth prospects of the Alpha Emitter Market business?

Who are the key manufacturers in the Alpha Emitter Market space?

What Forecast Period for Global Alpha Emitter Industry Report?

What are the main segments of the global Alpha Emitter Market?

What are the key metrics like opportunities and market drivers?

The Alpha Emitter Market Insights

Product Development/Innovation: Detailed Information On Upcoming Technologies, R&D Activities, And Product Launches In The Market.

Competitive Assessment: In-Depth Assessment Of Market Strategies, Geographic And Business Segments Of Key Market Players.

Market Development: Comprehensive Information On Emerging Markets. This Report Analyzes The Market For Different Segments In Different Regions.

Market Diversification: Comprehensive Information On New Products, Untapped Regions, Latest Developments, And Investments In The Alpha Emitter Market.

Check Out More Reports

Global Green Chemicals Market:  Report Forecast by 2032

Global Surgical Sutures Market: Report Forecast by 2032

Global Smart Workplace Market: Report Forecast by 2032

Global Wireless Access Control Market: Report Forecast by 2032

Global Geospatial Analytics Market: Report Forecast by 2032

[tumb11]

Europe "Wood Recycling Market 2022" | Current and Future Trends with Action Recovery and Recycling Pty Ltd, A & A Recycling Services Ltd, Hadfield Wood Recyclers, Wood Waste Technology

"https://tealfeed.com/triethylene-glycol-teg-market-huge-growth-tywzs https://tealfeed.com/cad-cam-dental-systems-market-2022-gfmx2 https://tealfeed.com/meeting-room-signs-market-2022-demand-rkjdg https://tealfeed.com/aroma-ingredients-market-2022-2027-coverage-qhqie https://tealfeed.com/sulphate-potash-sop-market-global-production-elgpu https://tealfeed.com/prader-willi-syndrome-market-size-incredible-9mcks https://tealfeed.com/satellite-market-size-growth-set-surge-ktpqu https://tealfeed.com/fly-ash-market-2022-top-leading-pcrcp https://tealfeed.com/newspaper-industry-future-demand-market-analysis-2sgyp https://tealfeed.com/silicone-oil-market-size-historical-growth-jue0y https://tealfeed.com/lead-free-solder-paste-market-industry-3cgms https://tealfeed.com/food-e-commerce-market-future-scope-fgagw https://tealfeed.com/fitness-equipment-market-2022-analysis-research-y0kls https://tealfeed.com/tallow-fatty-acids-market-2022-analysis-8nips https://tealfeed.com/flexible-elastomeric-foam-market-witness-huge-lw3z6 https://tealfeed.com/slurry-tankers-market-next-big-thing-4l5xq https://tealfeed.com/capacitive-vacuum-gauge-market-2022-2027-0qvvk https://tealfeed.com/new-report-annealing-laser-systems-market-26gby https://tealfeed.com/dental-laser-market-current-business-trends-dzhg3 https://tealfeed.com/food-safety-testing-technologies-market-demand-8gtky https://tealfeed.com/body-worn-cameras-market-size-share-wqydf https://tealfeed.com/veterinary-multi-parameter-monitors-industry-future-yau8b https://tealfeed.com/rotary-kiln-market-2022-latest-sales-6zcwc https://tealfeed.com/wearable-computing-devices-market-2022-top-nxstn https://tealfeed.com/blood-bank-market-2022-top-key-jxvpk https://tealfeed.com/applicant-tracking-software-market-2022-omicron-d6rds https://tealfeed.com/non-invasive-glucose-meter-market-size-bc7dy https://tealfeed.com/insurance-agency-tools-market-covid19-omicron-jrvff https://tealfeed.com/alpha-emitter-market-growth-possibilities-analysis-9hdh6 https://tealfeed.com/intra-ocular-lens-market-witness-huge-y0fe6 https://tealfeed.com/contact-tracing-app-market-pointing-capture-bdomg https://tealfeed.com/qr-bar-code-readers-2022-market-rtxul https://tealfeed.com/maritime-patrol-aircraft-market-2022-challenges-dflqq https://tealfeed.com/pick-to-light-system-market-expected-zsubt https://tealfeed.com/indium-market-size-scope-top-key-nmztd https://tealfeed.com/heart-failure-drugs-market-size-outlook-ak7gi https://tealfeed.com/panoramic-x-ray-system-market-2022-qk4qy https://tealfeed.com/grp-gre-pipe-market-size-analysis-hu1xh https://tealfeed.com/web-performance-market-size-set-grow-wlx4k https://tealfeed.com/refinery-catalyst-market-size-growth-set-uq39r https://tealfeed.com/elliptical-fitness-machine-market-expecting-outstanding-smtes https://tealfeed.com/ring-gear-market-2022-development-stat-glfie https://tealfeed.com/sales-management-tools-market-report-covers-yocdb https://tealfeed.com/spinal-surgical-robots-market-growth-trends-n3bi3 https://tealfeed.com/recruitment-staffing-market-challenges-opportunities-size-zurs6 https://tealfeed.com/pressure-ulcer-treatment-market-overview-demand-1kqh9 https://tealfeed.com/2022-stainless-steel-pipes-tubes-market-haxim https://tealfeed.com/zytel-handle-folding-knives-market-outlook-lgqzs https://tealfeed.com/power-factor-correction-devices-market-huge-xahzt https://tealfeed.com/wax-additives-market-2022-top-leading-qqf9j https://tealfeed.com/razor-blades-market-2022-demand-future-hqdya https://tealfeed.com/pet-kennel-market-2022-2027-coverage-f8nhu https://tealfeed.com/embedded-system-market-global-production-growth-vmnk5 https://tealfeed.com/structural-electronics-market-size-incredible-possibilities-dj72x https://tealfeed.com/air-fresheners-market-size-growth-set-heikp https://tealfeed.com/commercial-real-estate-market-2022-top-9vywg https://tealfeed.com/equipment-rental-software-industry-future-demand-po38u

[adityarana1687-blog]

Nuclear Medicine Market Assures To Achieve $12.6 Billion By 2027

The global nuclear medicine market size is expected to reach USD 12.6 billion by 2027, expanding at a CAGR of 9.5%, according to a new report by Grand View Research, Inc. Research and development of advanced technologies by the key players for diagnosis and treatment of diseases is expected to drive the radiopharmaceuticals market.

For instance, in May 2019, GE Healthcare with Indi Molecular, Inc., collaborated to develop Protein Catalyzed Capture (PCC) technology and immune cell-targeted PET tracer candidates. This diagnostic tool will help in better understanding of patient’s immune cell and in early treatment response.

Rising prevalence of cancer and cardiovascular diseases is one of the major factors responsible for market growth. Moreover, high prevalence of cancer in emerging Asian countries is creating huge demand for radiopharmaceuticals in diagnosing the disease. For instance, according to the GLOBOCAN, in 2018, approximately 48.4% of cancer cases were registered in Asia.

In addition, presence of standard guidelines prepared by regulatory authorities for radiopharmaceuticals is expected to accelerate market growth. For instance, in August 2019, FDA published a guideline for non-clinical studies and product labelling that are not covered by FDA and ICH guidelines for radiopharmaceuticals used in the treatment of cancer.

Manufacturers are focusing on development of innovative technologies to produce medical isotopes that can fulfill the increasing demand for nuclear medicines. For instance, in October 2018, with the support of ASML, The Institute For Radioelements (IRE) developed and built an electron beamline to manufacture medical isotope molybdenum 99 (Mo-99). Due to this innovative technology, the process of production is waste-free and non-fission.

In addition, research centers and hospitals are launching novel nuclear medicine techniques to treat various diseases at an affordable cost as compared to the existing treatments. For instance, in August 2017, the Kovai Medical Centre and Hospital (KMCH) had launched Rhenium 188 Lipiodol to treat liver cancer and other diseases such as metastatic bone pain, rheumatoid arthritis, and hemophilic bleeding joints at low cost with lesser hospitalization.

To request a sample copy or view summary of this report, click the link below: www.grandviewresearch.com/industry-analysis/nuclear-medicines-market

Further key findings from the study suggest:

In 2019, the SPECT segment had dominated the market owing to integration of SPECT with X-ray/CT that has gained more acceptance and proved to be useful in many clinical situations due to its high accuracy

PET diagnostic nuclear medicine is expected to witness the fastest growth over the forecast period owing to the increasing adoption of high resolution PET scanners

In case of the therapeutic segment, brachytherapy is anticipated to be the fastest growing segment due to the higher radiation protection as compared to other treatment options

The oncology application segment dominated the nuclear medicine market in 2019 owing to the presence of pipeline drugs and high prevalence of cancer

The market in Asia Pacific is projected to witness the fastest growth during the forecast period owing to the high unmet needs and development of radiopharmaceuticals for diagnosis and treatment of various diseases

Key players in the market include companies such as Eckert and Ziegler Group Nordion, Inc.; Bracco Imaging S.p.A.; and GE Healthcare as well as government organizations such as Department of Atomic Energy and Australian Nuclear Science and Technology Organization (ANSTO).

Grand View Research has segmented the global nuclear medicine market on the basis of product, application, and region:

Nuclear Medicine/Radiopharmaceuticals Product Outlook (Revenue, USD Million, 2016 - 2027)

Diagnostic products

Therapeutic Products

SPECT

PET

TC-99m

TL-201

GA-67

I-123

Other SPECT products

F-18

SR-82/RB-82

Other PET products

Alpha Emitters

Beta Emitters

Brachytherapy

RA-223

Other alpha emitters

I-131

Y-90

SM-153

Re-186

Lu-117

Other beta emitters

Cesium-131

Iodine-125

Palladium-103

Iridium-192

Other brachytherapy products

Nuclear Medicine/Radiopharmaceuticals Application Outlook (Revenue, USD Million, 2016 - 2027)

Cardiology

Neurology

Oncology

Thyroid

Lymphoma

Bone Metastasis

Endocrine Tumor

Others

Nuclear Medicine/Radiopharmaceuticals Regional Outlook (Revenue, USD Million, 2016 - 2027)

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

U.S

Canada

Germany

U.K.

France

Italy

Spain

Russia

Netherlands

Japan

China

India

Australia

Singapore

Malaysia

New Zealand

South Korea

Philippines

Brazil

Mexico

Argentina

Saudi Arabia

South Africa

Israel

Turkey

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

[mysteriouslysizzlingobserva-blog]

Global Nuclear Medicine/Radiopharmaceuticals Market

Global Nuclear Medicine/Radiopharmaceuticals Market is expected to reach USD 9.54 Billion by 2024 from USD 4.69 Billion in 2016 at CAGR of 9.28% (Detailed analysis of the market CAGR is provided in the report).

Nuclear Medicine/Radiopharmaceuticals is used for diagnosis and treatment of various diseases that conventional medicines fail to achieve. Nuclear Medicine/Radiopharmaceuticals diagnose certain medical problems or treat certain diseases condition with various agents. Global Nuclear Medicine/Radiopharmaceuticals Market is segmented by type, procedural volume, application, and geography. Type segment is sub segmented as diagnostic nuclear medicine and therapeutic nuclear medicine/ radiopharmaceuticals. Application segment is divided into Diagnostic Applications, Therapeutic Applications, and Other Therapeutic Applications. SPECT application segment is expected to register highest market growth during the forecast period, owing to SPECT presence of well-established imaging market and the extensive usage of SPECT radioisotopes for the diagnosis of cancer, cardiovascular diseases, thyroid, and neurological disorders. The market on the basis of geography is segmented by North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America. Increasing incidence and prevalence of cancer and cardiac ailments are trending the overall Global Nuclear Medicine/Radiopharmaceuticals Market. However, a high cost of nuclear medicine equipment will restrain the market growth. North America is expected to dominate the Nuclear Medicine/Radiopharmaceuticals Market in forecast period followed by Europe and APAC. Presence of a well establish healthcare industry for the adoption of modern treatments and diagnostic procedures and raising awareness regarding the advantages that radiopharmaceuticals have to offer will fuel the Nuclear Medicine/Radiopharmaceuticals Market in North America region.

For More Information Visit https://www.maximizemarketresearch.com/market-report/global-nuclear-medicine-radiopharmaceuticals-market/7741/

  Key Highlights: • Assessment of market definition along with the identification of key players and an analysis of their strategies to determine the competitive outlook of the market, opportunities, drivers, restraints, and challenges for this market during the forecast period • Complete quantitative analysis of the industry from 2016 to 2024 to enable the stakeholders to capitalize on the prevailing market opportunities • In-depth analysis of the industry on the basis of market segments, market dynamics, market size, competition & companies involved value chain • Global Nuclear Medicine/Radiopharmaceuticals Market analysis and comprehensive segmentation with respect to the type, procedural volume, application, and geography to assist in strategic business planning • Global Nuclear Medicine/Radiopharmaceuticals Market analysis and forecast for five major geographies North America, Europe, Asia Pacific, Middle East & Africa, Latin America and their key regions Research Methodology The market is estimated by triangulation of data points obtained from various sources and feeding them into a simulation model created individually for each market. The data points are obtained from paid and unpaid sources along with paid primary interviews with key opinion leaders (KOLs) in the market. KOLs from both, demand and supply side were considered while conducting interviews to get an unbiased idea of the market. This exercise was done at a country level to get a fair idea of the market in countries considered for this study. Later this country-specific data was accumulated to come up with regional numbers and then arrive at the global market value for Global Nuclear Medicine/Radiopharmaceuticals Market.

Key Players in the Global Nuclear Medicine/Radiopharmaceuticals Market Are: • Advanced Accelerator Applications S.A. • Iba Molecular • Nordion, Inc. (A Subsidiary of Sterigenics International LLC.) • Eczacibasi-Monrol Nuclear Products • Siemens Healthcare • Sigma Aldrich Corporation • Bracco Imaging S.P.A • Bayer AG • Jubilant Pharma • Nordien, Inc. • Lantheus Medical Imaging, Inc. • GE Healthcare (A Fully-Owned Subsidiary of General Electric Company) • Mallinckrodt PLC • Cardinal Health, Inc. • Medtronic Plc. Key Target Audience: • Research and Consulting Firms as well as Venture capitalists, private equity firms, and startup companies • Radiopharmaceutical/Radioisotope Manufacturers and Distributors • Healthcare Institutions (Hospitals, Medical Schools, and Outpatient Clinics) • Contract Manufacturing Organizations (CMOs) • Contract research organizations (CROs) • Government Bodies Scope of the Report: Research report categorizes the Global Nuclear Medicine/Radiopharmaceuticals Market based on type, procedural volume, application, and geography (region wise). Market size by value is estimated and forecasted with the revenues of leading companies operating in the Global Nuclear Medicine/Radiopharmaceuticals Market with key developments in companies and market trends. Global Nuclear Medicine/Radiopharmaceuticals Market, By Procedural Volume • Diagnostic Procedures o SPECT Radiopharmaceuticals o PET Radiopharmaceuticals • Therapeutic Procedures o Beta Emitters o Alpha Emitters o Brachytherapy Isotopes Global Nuclear Medicine/Radiopharmaceuticals Market, By Type • Diagnostic Nuclear Medicine o SPECT Radiopharmaceuticals o PET Radiopharmaceuticals • Therapeutic Nuclear Medicine/ Radiopharmaceuticals o Beta Emitters o Alpha Emitters o Brachytherapy Isotopes Global Nuclear Medicine/Radiopharmaceuticals Market, By Application • Diagnostic Applications o SPECT Applications o PET Applications • Therapeutic Applications o Thyroid o Bone Metastasis o Lymphoma o Endocrine Tumors • Other Therapeutic Applications Global Nuclear Medicine/Radiopharmaceuticals Market, By Geography • North America • Europe • Asia Pacific • Middle East & Africa • Latin America

This Report Is Submitted By @Global Market Research Company

Customization of the report:

Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.

About Maximize Market Research:

Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

  Contact info:

Name: Lumawant Godage

Organization: MAXIMIZE MARKET RESEARCH PVT. LTD.

Email: sales@maximizemarketresearch.com

Address: Omkar Heights, Sinhagad Road, Manik Baug, Vadgaon Bk, Pune, Maharashtra 411051, India.

Contact: +919607065656/ +919607195908

[insightslice]

Estimated Impact of COVID-19 Epidemic on the Nuclear Medicine Market Growth in 2020, by Region and Scenario

The nuclear medicine is an intricate branch of medical science that uses radiopharmaceuticals for detection and diagnostic procedures. The radiopharmaceuticals consist of radioisotopes produced through particle accelerator such as the medical cyclotron and are used for targeted therapy, detection based imaging and therapeutics. With advancement in medical technology, the imaging and diagnostic devices have evolved significantly. The nuclear medicines are used in the diagnostic imaging equipment to increase the efficacy of diagnosis and thus are gaining popularity worldwide. The radiopharmaceuticals are also used in the treatment of cancer, thyroid, bone metastasis, arthritis and so on, wherein doses of doses of ionizing radiation are delivered to diseases sites for curative or palliative applications. The nuclear medicines or radiopharmaceuticals are administered in very small quantities and thus does not possess any side effect. This has fueled the development of advanced radiopharmaceuticals and is anticipated to be a major factor driving the growth of the global nuclear medicine market during the forecast period.

North America contributed the largest share to the global nuclear medicine market in 2019 and is anticipated to be a dominating geography during the forecast period. The key factors driving the growth of nuclear medicine marker in North America are increasing investment in novel drug discovery, early adoption of nuclear medicine in therapeutic & diagnostic applications, and prevalence of chronic diseases primarily cancer & cardiovascular diseases. Asia Pacific contributed a significant share to the global nuclear medicine market in 2019 and is anticipated to be the fastest growing segment during the forecast period. Increasing investment in expansion of biotechnology and pharmaceutical industry, and rising adoption of advanced therapeutic and diagnostic technologies are expected to drive the Asia Pacific nuclear medicine market in coming years.

The report titled “Nuclear Medicine (Radiopharmaceuticals) Market – Global Market Share, Trends, Analysis and Forecasts, 2020-2030” offers market estimates for a period 2018 to 2030, wherein 2018 is historic period, 2019 is the base year, and 2020 to 2030 is forecast period. Additionally, the study takes into consideration the competitive landscape, wherein the report would provide company overview and market outlook for leading players in the global nuclear medicine market. Furthermore, the report would reflect the key developments, global & regional sales network, business strategies, research & development activities, employee strength, and key executive, for all the major players operating in the market. For instance, Bayer AG reported revenues of USD 46.8 billion in 2019 and the product segment analysis of the company indicates that Crop Science business segment of the company dominated revenue in 2019.

The global nuclear medicine (radiopharmaceuticals) market is segmented based on product type, applications, end user, and geography. Based on product type, the global nuclear medicine market is segmented into diagnostic nuclear medicine, therapeutic nuclear medicine, and brachytherapy isotopes. The diagnostic nuclear medicine is sub-segmented into single-photon emission computed tomography (SPECT) radiopharmaceuticals (Technetium-99m, Thallium-201, Gallium-67, Iodine-123, Other), and positron-emission tomography (PET) radiopharmaceuticals (F-18, Ru-82, Other). The therapeutic nuclear medicine is segmented into alpha emitters, and beta emitters (Iodine-131, Yttrium-90, Samarium-153, Lutetium-177, Rhenium-186, Other). The brachytherapy isotopes are sub-segmented into Iodine-125, Palladium-103, Cesium-131, Iridium-192, and other. Based on applications, the global nuclear medicine market is segmented into oncology, cardiology, neurology, thyroid, and others. Based on end user, the global nuclear medicine market is segmented into hospitals & diagnostic centers, and research institutes. Based on geography, the global nuclear medicine market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America.

Request PDF Sample: https://www.insightslice.com/request-sample/364

The research provides in-depth analysis of prominent players holding majority share of the global market with a focus on all operating business segment, and would identify the segment of the company focusing on Nuclear Medicine (Radiopharmaceuticals). Further, market share of prominent companies in the global Nuclear Medicine (Radiopharmaceuticals) market would also be estimated. For instance, Bayer AG operates through three business segments namely Crop Sciences, Pharmaceuticals, and Consumer Health. The nuclear medicines products are delivered under Pharmaceuticals business segment of the company with revenue contribution of US$ 19,337.1 million in 2019.

[megasddw-blog]

Radiopharmaceutical Market Overview with Detailed Analysis, Competitive landscape, Forecast to 2023

The Report of “Radiopharmaceutical Market” Research Future Covers the Information like Market, Prominent Players and Radiopharmaceutical Market Market Segmentation, Regional Outlook, End-User and Forecast to 2023.

Radiopharmaceuticals are radioisotopes used for the therapeutic and diagnosis purposes and play a crucial role in the medical diagnosis. Radiopharmaceutical can be used with imaging devices to study the dynamic processes taking place in various parts of the body. The global radiopharmaceutical market likely to attain USD 10,473.88 Mn at a CAGR of 8.7% over the forecast period of 2017-2023. The key factors influencing the growth of the global radiopharmaceutical market include the massive shift of the healthcare industry towards a personalized approach towards diagnosis and treatment.

Widespread prevalence of chronic diseases such as cancer, cardiovascular diseases and others have generated huge demand for treatment and diagnosis which has provided an impetus to the growth of the market. In addition, growing incidence rate of oncology diseases creates the need for cancer management which is anticipated to be plus for the growth of the global radiopharmaceutical market. On the other hand, risks associated with radiopharmaceuticals are expected to e hurdle to the growth of the global radiopharmaceutical market. Low feasibility of treatment and high costs of devices might also impede the growth of the market over the forecast period.

Request Free Sample Copy at https://www.marketresearchfuture.com/sample_request/1650

Competitive Landscape

The key players in the global radiopharmaceutical market include Medtronic, Canadian Nuclear Laboratories (CNL), Jubilant Life Sciences Ltd., Lantheus Medical Imaging, Inc., Bayer AG, Advanced Accelerator Applications S.A., Bracco Diagnostic Inc., Mallinckrodt Pharmaceuticals, General Electric Company (GE Healthcare), Cardinal Health Inc., IBA Dosimetry GmbH, Siemens AG, Nordion, Inc., Sun Pharmaceutical Industries Ltd., and Avid  Radiopharmaceuticals.

Industry Updates

In January 2019, RadioMedix Inc., a biotechnology company focused on targeted radiopharmaceuticals and Curium, a leader in radiopharmaceuticals, announced that FDA has granted Fast Track designation to their diagnostic radiopharmaceutical, 64Cu-Dotatate.

Segmentation

The global radiopharmaceutical market has been segmented based on type, type of test, application, route of administration, and end user.

By type, the global radiopharmaceutical market has been segmented into diagnostic type radiopharmaceuticals and therapeutic type radiopharmaceuticals. The diagnostic type radiopharmaceutical segment has been further segmented into SPECT radiopharmaceutical and PET radiopharmaceutical. The SPECT radiopharmaceutical sub segment has been further segmented into Technetium-99m, Thallium-201, Iodine-123, and others. The PET radiopharmaceutical sub segment has been further segmented into  F-18, Rubidium-82, and others.

The therapeutic type radiopharmaceutical segment has been further segmented into beta emitters, alpha emitters, brachytherapy. The beta emmiters sub-segment has been further segmented into Iodine-131, Yttrium-90, Samarium-153, Rhenium-186, Lutetium-177, and others. The brachytherapy sub segment has been further segmented into Iodine-125, Iridium-192, Cesium-131, and others.

By type of test, the global radiopharmaceutical market has been segmented into bone scan, white blood cell scan, myocardial perfusion scan, lung scan, parathyroid scans, hepatobiliary scans, gallium scan, renal nuclear medicine scan, cerebral perfusion scan and others. The bone scan segment has been further segmented into Technetium-99m 1st, fluoride-18 2nd, and others. The Myocardial Perfusion Scan segment has been further segmented into Technetium-99m, Thallium-201, Rubidium-82, and others. The lung scan segment has been further segmented into Xenon-133, Krypton-81m, and others. The white blood cell scan segment has been further segmented into Indium-111 and others.

By application, the global radiopharmaceutical market has been segmented into oncology, cardiology, neurology, urology, and others. The oncology segment has been further segmented into prostate cancer, bone cancer, breast cancer and others. The cardiology segment has been further segmented into coronary artery disease, cardiomyopathy and others. The neurology segment has been further segmented into traumatic brain injury, stroke, Alzheimer’s disease and others. The urology segment has been further segmented into acute pyelonephritis, congenital renal anomalies, and others.

By route of administration, the global radiopharmaceutical market has been segmented into oral, intravenous and others.

By end user, the global radiopharmaceutical market has been segmented into hospitals, diagnostic centres, research institutes and others.

Regional Analysis

By region, the global radiopharmaceutical market has been segmented into the Americas, Europe, Asia Pacific, and the Middle East & Africa. The Americas and Europe collectively account for the foremost share of the global market. High healthcare expenditure, robust healthcare sector and prevalence of chronic diseases in these regions such as cancer, coronary disorders, stroke among others are driving the market in theses region. High investment in R&D activities and presence of huge patient pool and market players augur the growth of these markets. The Americas is the larges market while Europe follows the Americas closely. APAC is poised to be the fastest growing market for radiopharmaceuticals. Expanding patient population base, surging prevalence of chronic diseases stimulate the growth of the market. High healthcare spending in the emerging economies of the region coupled with rising awareness which generate huge demand for diagnostics has fueled the growth of the market in the region.

Access Full Report at https://www.marketresearchfuture.com/reports/radio-pharmaceutical-market-1650

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

[ashwinigongale-blog]

Global Nuclear Medicine & Radio Pharmaceuticals Market Trend, Marketing Channels, Major Industry Participants, Strategies  and Forecast To 2024

A new research report data added to the Market.biz titled Global Nuclear Medicine & Radio Pharmaceuticals Market gives a proper understanding of the industry and it also predicts current market trends and future market trends. The report presents a detailed picture of the market by way of study, synthesis, and addition of data from multiple sources. Global Nuclear Medicine & Radio Pharmaceuticals market analyses the report based on customer demand, supply and demand status, competitive market scenario and industry policies.

Here, you can avail Sample Copy for Global Nuclear Medicine & Radio Pharmaceuticals Market Report

The Nuclear Medicine & Radio Pharmaceuticals market report presents the overall structure of the market like the major market players based on the company profile, sales revenue, the business tactics used in the global Nuclear Medicine & Radio Pharmaceuticals market which will help the emerging market segments in making vital business decisions. Also, the report discusses business plans, sales and profit, market stations and market volume, raw material suppliers, and buyers demand information and distribution ratio.

Competitive landscape

The competitive landscape segment in the report relies on the current as well as the potential of the leading market players in the industry. It offers the in-depth company profiles, that may stay active in predestined decades, combined with company profile, product launches, product market, and gross margin, financial details, key advancements, business short-term and long-term marketing, and advertising strategies and SWOT analysis of these competitive firms.

Nuclear Medicine & Radio Pharmaceuticals Market: Top Companies

Toshiba

Carestream

Esaote

Siemens Healthcare

Biosensors International Group Ltd.

GE Healthcare

Hitachi

TriFoil Imaging

Philips Healthcare

Shimadzu

 Market Segmentation

The report provides global market segmentation based on the product type, end-users, and region. In the additional section, the report includes market division study over the significant geographies of the world such as North America, Asia-Pacific, Europe, South America, The Middle East & Africa and the rest of the world. The report covers worldwide statistic which is focused on the global market.

Nuclear Medicine & Radio Pharmaceuticals Product types Outlook:

Diagnostic Medicine SPECT Radiopharmaceuticals

PET Radiopharmaceuticals.

Therapeutic Medicine Beta Emitters

Alpha Emitters

Brachytherapy Isotopes.

 Nuclear Medicine & Radio Pharmaceuticals Applications Outlook:

Diagnostic Applications: SPECT

PET.

Therapeutic Applications: Thyroid

Bone Metastasis

Lymphoma

Endocrine Tumors

Therapeutic Applications.

 Geographically, the key segments of the market are:

North America

Europe

China

Japan

The Middle East & Africa

India

South America

Make an Inquiry to Get Global Nuclear Medicine & Radio Pharmaceuticals report as your requirement

Global Nuclear Medicine & Radio Pharmaceuticals Market Report mainly covers the following significant points:

1. An outlook of the Nuclear Medicine & Radio Pharmaceuticals industry;

2. Market Competitive Landscape;

3. Top Players Company Profiles;

4. Analysis of the product types of Nuclear Medicine & Radio Pharmaceuticals;

5. Analysis of the Applications/End-Users of Nuclear Medicine & Radio Pharmaceuticals;

From the conclusion of this study, all the answers to the queries will be well guided as it focuses on analytical research and mainly includes qualitative and quantitative analysis. this analyzed report can give an in-depth summary of upcoming and ongoing which leads to market development on a global scale.

Click Below If You Want More Related Reports:

Global Pediatric Nebulizers Market

Global Titanium Dioxide Rutile Market

Global Ito Target Market

Global Uv Stabilizer Barrier Coating Market

[amanjadejablog]

Therapeutic Nuclear Medicines Market Forecast ‑ Industry Value, Size, Top Companies and Trends for 2019-2025

“The Therapeutic Nuclear Medicines market report is a complete research on the current state of the Therapeutic Nuclear Medicines market with a focus on the regional market. This report presents the global Therapeutic Nuclear Medicines market size (value, production, and consumption), splits the breakdown (data status 2013-2018 and forecast to ‘2025’), by manufacturers, region, type, and application. This study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter’s Five Forces Analysis.

This research is helpful for all the players operating in the market, including the well-established players and the new entrants. This intelligent study provides the definition, description, and the overall forecasts of the global market, considering the market segments and sub-segments, which includes the product types, technologies, end-users, industry verticals, and the key geographies. Moreover, the report also provides an in-depth analysis of some of the significant factors such as driving forces, challenges, and threats that will shape the future of the market. In addition, the report also includes the lucrative opportunities in the micro markets for all the participants to invest in the global Therapeutic Nuclear Medicines market. Besides, the report describes the product offerings and the competitive analysis of the major players operating in the market.

Get a FREE Sample PDF Report: https://www.marketgrowthinsight.com/sample/18805

The report also presents the market competitive landscape and a corresponding detailed analysis of the major vendor/key players in the market.

The key players covered in this report: 

• The major manufacturers covered in this report Cardinal Health Mallinckrodt GE Healthcare Lantheus Medical Imaging Bayer Bracco Imaging Eczacibasi-Monrol Nuclear Products Nordion Advanced Accelerator Applications IBA Molecular Imaging

• Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering North America Europe China Japan Southeast Asia India

• On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into Beta Emitters Alpha Emitters Brachytherapy Products

• On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including Thyroid Bone Metastasis Lymphoma Endocrine Tumors Others

• Key Stakeholders Therapeutic Nuclear Medicines Manufacturers Therapeutic Nuclear Medicines Distributors/Traders/Wholesalers Therapeutic Nuclear Medicines Subcomponent Manufacturers Industry Association Downstream Vendors

This report studies the global Therapeutic Nuclear Medicines market status and forecast, categorizes the global Therapeutic Nuclear Medicines market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia).

Get Discount on this Report: https://www.marketgrowthinsight.com/discount/18805

The prime objective of this Therapeutic Nuclear Medicines research report is to define the size of the different segments and the geographies as well as to forecast the trends that are likely to gain traction in the following couple of years. This market research report has been designed to incorporate both the qualitative and quantitative aspects of the industry within each of the regions.

The scope of this report centers on key market analyses, market drivers & challenges, and competitive analysis & trends. Research report examines each market and its applications, regulatory scenario, technological innovations, Therapeutic Nuclear Medicines market projections, market sizes, and shares. Moreover, the Therapeutic Nuclear Medicines market report examines the most recent trends, pipeline products and developments in the Therapeutic Nuclear Medicines market. Complete profiles of leading organizations in the market are also mentioned in this report.

Therapeutic Nuclear Medicines market report highlights: 1. The Therapeutic Nuclear Medicines research report provides a detailed survey of the current and future industry trends so as to identify the investment analysis. 2. The industry forecasts, using estimated market values have been mentioned, till ‘2025’. 3. The Therapeutic Nuclear Medicines Market dynamics such as the drivers, restraints, threats, opportunities, and industry-specific challenges 4. Key industry trends across all the market segments and sub-segments, geographies, and nations. 5. Key developments and strategies determined in the market. 6. Detailed profiling of the leading competitors and the entrant market players. 7. Growth prospects among the emerging nations throughout the forecast period. 8. The Therapeutic Nuclear Medicines Market opportunities and recommendations for new investments.

In the end, It includes the methodical description of the various factors such as the market growth and a detailed information about the different company’s revenue, growth, technological developments, production, and the various other strategic developments.

Purchase Therapeutic Nuclear Medicines Market Research Report: https://www.marketgrowthinsight.com/checkout/18805

Thus, the Therapeutic Nuclear Medicines Market Report serves as a valuable material for all industry competitors and individuals having a keen interest in Therapeutic Nuclear Medicines Market study.

About us : Market Growth Insight, is a one stop solution for market research reports in various business categories. We are serving 100+ clients with 10000+ diverse industry reports and our reports are developed to simplify strategic decision making, on the basis of comprehensive and in-depth significant information, established through wide ranging analysis and latest industry trends. Contact us : 502, Sai Radhe, Kenedy Road, Behind Hotel Sheraton Grand, Near Pune Station, Pune-411001, sales@marketgrowthinsight.com + 91 8956 049 020

Connect With Us : Twitter | Linkedin | Facebook | Google+

  from WordPress http://bit.ly/2XfS5Rt via IFTTT

[crystalmarketresearch]

Radiopharmaceuticals Market Is Expected to Increase to US$ 8.77 billion by 2023

A research study titled, “Radiopharmaceuticals Market by type, procedural volumes and application- global industry analysis and forecast to 2023” published by crystal market research. Competitive Analysis: The leading players in the market are Bracco Imaging S.p.A, IBA Molecular Imaging India Private Limited, Wipro GE Healthcare Pvt Ltd, Bayer HealthCare Pharmaceuticals LLC, Nordion Inc, Lantheus Medical Imaging Inc, Cardinal Health, Advanced Accelerator Applications and Mallinckrodt.

Click to Request a Sample: https://www.crystalmarketresearch.com/report-sample/HC01517

Industry Outlook & Trend Analysis: The global Radiopharmaceuticals market was worth USD 3.89 billion in 2014 and is expected to reach approximately USD 8.77 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 9.45% during the forecast period. 

The market is right now in its development phase driven by expanding number of disease cases and increasing awareness about nuclear medication. Radiopharmaceuticals are pharmaceutical formulations involving radioactive isotopes that are useful as a part of analysis and therapeutics. They are basic and small substances that contain a radioactive substance that is useful as a part of the treatment of cancer and neurological and cardiac disorders. The regular chemotherapy techniques are being supplanted by more advantageous helpful radiopharmaceuticals for oncology and cancer treatment, which opens up new roads in the radiopharmaceuticals market. Type Outlook and Trend Analysis On the basis of type, the market is fragmented into therapeutic and diagnostic. The diagnostic portion represented the biggest share of the nuclear medicine market. The diagnostic portion is additionally fragmented into PET and SPECT. In 2016, the SPECT section represented the biggest share of the radiopharmaceuticals diagnostic market. The therapeutic fragment is additionally divided into brachytherapy, alpha emitters, and beta emitters. 

Application Outlook and Trend Analysis Based on application, the radiopharmaceuticals market is fragmented into PET, SPECT and therapeutic applications. In 2016, the cardiology application section represented the biggest share of the atomic medication SPECT applications market. The atomic radiopharmaceuticals PET applications market was ruled by the oncology section, while the radiopharmaceuticals therapeutic applications market was ruled by the thyroid application fragment.

By Procedural Volumes Diagnostic Procedures SPECT Radiopharmaceuticals PET Radiopharmaceuticals Therapeutic Procedures Beta Emitters Alpha Emitters Brachytherapy Regional Outlook and Trend Analysis Geographically, the market is fragmented into Europe, North America, Asia-Pacific, and the Rest of the World.  North America is accounted for the biggest share, trailed by Asia-Pacific and Europe In 2016. The Asia-Pacific locale is foreseen to develop at the most elevated CAGR amid the estimate time frame. This high development can be ascribed to the establishment of PET scanners in India and activities by the legislature of the Asian nations to advance health among others. Table of Contents: Introduction Executive Summary Market Overview Market Analysis by Region Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) North America (U.S, Canada, Mexico) Europe (Germany, France, UK, Italy, Spain, Rest of Europe) Asia-Pacific (Japan, China, Australia, India, South Korea, Rest of Asia-Pacific) Rest of the World (Brazil, South Africa, Saudi Arabia, Turkey, United Arab Emirates, Others) Check discount offer for Report click on the link https://www.crystalmarketresearch.com/check-discount/HC01517

About Crystal Market Research: Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy. Contact Us: Judy S, 304 South Jones Blvd, Suite 1896, Las Vegas NV 89107, United States Toll Free: +1-888-213-4282 Email: sales@crystalmarketresearch.com

[ahila-blog1]

Global Radiopharmaceuticals/Nuclear Medicine Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

Global Radiopharmaceuticals (Nuclear Medicine) Market: By Product Type (Diagnostic Radiopharmaceuticals (SPECT Radiopharmaceuticals and PET Radiopharmaceuticals) and Therapeutic Radiopharmaceuticals (Beta Emitters, Alpha emitters, Brachytherapy, and Others)), By Application (Oncology, Neurological disorders, Cardiovascular diseases, Thyroid, and Others), By Route of Administration (Oral, Inhalation, and Parenteral) By End User (Hospitals, Clinics, Diagnostic Centers, and Research Institutes), and Geography (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa) – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

 Global Radiopharmaceuticals (Nuclear Medicine) Market Outline:

 Global radiopharmaceuticals (nuclear medicine) market report gives a comprehensive outlook on radiopharmaceuticals across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA). The report on radiopharmaceuticals/nuclear medicine market gives historical, current, and future market sizes (US$ Mn) on the basis of product type, application area, route of administration, end user, and geographic regions. This report studies Global radiopharmaceuticals (nuclear medicine) market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, radiopharmaceuticals/nuclear medicine market report includes new product introductions; regulatory scenario and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed radiopharmaceuticals market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the Global radiopharmaceuticals (nuclear medicine) market report include suppliers, manufacturers, marketers, policymakers, and healthcare service providers engaged in manufacturing, supply and prescribing of radiopharmaceuticals.

           A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-radiopharmaceuticals-nuclear-medicine-market/#ulp-4H8Z4LpNMLEuOnnx

  Global Radiopharmaceuticals/Nuclear Medicine Market:

 Global radiopharmaceuticals market estimated to be valued US$ 5,146 Mn in 2017 and poised to grow at CAGR of 8.9% over 2017-2023. The market for radiopharmaceuticals projected to reach US$ 8,564 Mn by 2023 owing to increasing adoption in radiotherapeutic and diagnostic procedures across the globe.

 Growing prevalence of cancer and cardiovascular diseases expected to drive adoption of radiopharmaceuticals across the globe

 The global radiopharmaceutical market is growing at a significant CAGR due to rising in the prevalence of various types of cancers and cardiovascular diseases. The growing prevalence of various cancers resulted in an increased adoption of radiopharmaceuticals in diagnosis and treatment of several cancers in developed economies. For instance, according to globocan cancer statistics, There were 14.1 million new cancer cases, 8.2 million cancer deaths and 32.6 million people living with cancer (within 5 years of diagnosis) in 2012 worldwide.  Moreover, advances in technology such as introduction of PET radiotracers and targeted radioimmunotherapies expected to drive the overall market revenue growth over the forecast period

 Emergence of radiopharmaceuticals as safer alternative to the conventional diagnosis

 The development of effective radiopharmaceuticals for diagnosis and treatment expected to drive the market revenue growth over the forecast period. The advances in imaging devices with radio-activity are aiding healthcare professionals in effective diagnosis. Moreover, radio-imaging diagnosis is considered as an effective alternative to the conventional diagnosis techniques such as X-rays which expected to boost the market demand for diagnostic radiopharmaceuticals across the globe. In addition, increase in the healthcare expenditure, radiopharmaceuticals abundance, and non-invasiveness in the treatment and diagnostic procedure might bolster the nuclear medicine market over the forecast period.

 To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-radiopharmaceuticals-nuclear-medicine-market/#ulp-c654SbFYO64MsOhu

  North America accounts for larger revenue share in global radiopharmaceuticals market

 North America market holds the higher revenue share in global radiopharmaceuticals market and projected to remain same over the forecast period owing to rising FDA approvals and production of radiopharmaceuticals in the region. Asia-pacific radiopharmaceuticals market projected to grow at significant CAGR over the forecast period in comparison with other regions owing to conducive business environment and rising PET installations in the region

     Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-radiopharmaceuticals-nuclear-medicine-market/#ulp-14mlyhjMGhVjZqa3

  Competition Assessment

 Key players profiled in the global Radiopharmaceuticals market include:

·         Advanced Accelerator Applications S.A. (France)

·         Bayer AG (Germany)

·         Bracco Imaging S.p.A (Italy)

·         Cardinal Health, Inc. (U.S.)

·         Eli Lilly and Co. (U.S.)

·         GE Healthcare (U.S.)

·         IBA Molecular Imaging (Belgium)

·         Jubilant Life Sciences Ltd (India)

·         Lantheus Medical Imaging, Inc. (U.S.)

·         Mallinckrodt plc (Ireland)

·         Navidea Biopharmaceutical (U.S.)

·         Nordion, Inc. (Canada)

·         Siemens Healthineers (Germany)

Players in the radiopharmaceuticals market are focusing on expanding product portfolio, acquisitions to garner larger market revenue share in global radiopharmaceuticals market.

   Key Findings of the Report:

 ·         Global Radiopharmaceuticals market expanding at 8.9% CAGR over 2017 to 2023 to reach market value of US$ 8,564 Mn by 2023

·         Based on product type, diagnostic radiopharmaceuticals accounted for larger market revenue share in 2016 owing to wider application in various diagnostic procedures across the regions and expected to grow at significant rate

·         Oncology application segment accounted for larger market revenue share in 2016 expected to remain attractive over the forecast period owing to growing prevalence of various cancers

·         Players are focusing on production of radiopharamceuticals to expand market presence in global radiopharmaceuticals market.

Key Features of the Report:

 ·         The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023)

·         The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies

·         The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market

·         The report tracks recent innovations, key developments and startup’s details that are actively working in the market

·         The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario

·         The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

 Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-radiopharmaceuticals-nuclear-medicine-market/

About Precision Business Insights

 Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

 Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth.

 Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights

 Contact to Precision Business Insights,

 Kemp House,

 152 – 160 City Road,

 London EC1V 2NX

 Email: sales@precisionbusinessinsights.com

 Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

[marktaylor3114-blog]

2018 United States Nuclear Medicine & Radio Pharmaceuticals Market Shows Speedy Growth.

“United States Nuclear Medicine & Radio Pharmaceuticals Industry Report" is an expert and in-depth analysis of key business and future development prospects, key determinants and restrictions, profiles of major market players, segmentation and forecasting. The study offers a comprehensive qualitative analysis of the industry's growth parameters, the current state of the market in terms of analysis of key economic situations and macroeconomic analysis. The analysis highlights the growth opportunities of key market segments along with the tactical moves made by key vendors to grow in the market.

You can get a single user copy at USD 3800 and can get discount on it @ https://www.researchtrades.com/discount/1539295

Scope of the Report:

“In this report, the United States Nuclear Medicine & Radio Pharmaceuticals market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.”

On the basis of Key Regions, this report splits the United States market into seven regions:

The West

Southwest

The Middle Atlantic

New England

The South

The Midwest

with sales (volume), revenue (value), market share and growth rate of Nuclear Medicine & Radio Pharmaceuticals in these regions, from 2013 to 2025 (forecast).

United States Nuclear Medicine & Radio Pharmaceuticals market competition by Top Manufacturers/Players, with Nuclear Medicine & Radio Pharmaceuticals sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

GE Healthcare

Philips Healthcare

Siemens Healthcare

Toshiba

Hitachi

Carestream

Esaote

Shimadzu

TriFoil Imaging

Biosensors International Group, Ltd

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals

Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

Diagnostic Applications: SPECT, PET.

Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications.

 Get FREE and detailed sample copy of updated Analysis & Status @ https://www.researchtrades.com/request-sample/1539295

NOTE: If you have any special requirements, please let us know and we will offer you the report as you want

 Table of Content:

1 Nuclear Medicine & Radio Pharmaceuticals Overview

1.1 Product Overview and Scope of Nuclear Medicine & Radio Pharmaceuticals

1.2 Classification of Nuclear Medicine & Radio Pharmaceuticals by Product Category

1.2.1 United States Nuclear Medicine & Radio Pharmaceuticals Market Size (Sales Volume) Comparison by Type (2013-2025)

1.2.2 United States Nuclear Medicine & Radio Pharmaceuticals Market Size (Sales Volume) Market Share by Type (Product Category) in 2017

1.2.3 Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals

1.2.4 Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes

1.3 United States Nuclear Medicine & Radio Pharmaceuticals Market by Application/End Users

1.3.1 United States Nuclear Medicine & Radio Pharmaceuticals Market Size (Consumption) and Market Share Comparison by Application (2013-2025)

1.3.2 Diagnostic Applications: SPECT, PET.

1.3.3 Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications.

1.4 United States Nuclear Medicine & Radio Pharmaceuticals Market by Region

1.4.1 United States Nuclear Medicine & Radio Pharmaceuticals Market Size (Value) Comparison by Region (2013-2025)

1.4.2 The West Nuclear Medicine & Radio Pharmaceuticals Status and Prospect (2013-2025)

1.4.3 Southwest Nuclear Medicine & Radio Pharmaceuticals Status and Prospect (2013-2025)

1.4.4 The Middle Atlantic Nuclear Medicine & Radio Pharmaceuticals Status and Prospect (2013-2025)

1.4.5 New England Nuclear Medicine & Radio Pharmaceuticals Status and Prospect (2013-2025)

1.4.6 The South Nuclear Medicine & Radio Pharmaceuticals Status and Prospect (2013-2025)

1.4.7 The Midwest Nuclear Medicine & Radio Pharmaceuticals Status and Prospect (2013-2025)

1.5 United States Market Size (Value and Volume) of Nuclear Medicine & Radio Pharmaceuticals (2013-2025)

1.5.1 United States Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate (2013-2025)

1.5.2 United States Nuclear Medicine & Radio Pharmaceuticals Revenue and Growth Rate (2013-2025)

 2 United States Nuclear Medicine & Radio Pharmaceuticals Market Competition by Players/Suppliers

2.1 United States Nuclear Medicine & Radio Pharmaceuticals Sales and Market Share of Key Players/Suppliers (2013-2018)

2.2 United States Nuclear Medicine & Radio Pharmaceuticals Revenue and Share by Players/Suppliers (2013-2018)

2.3 United States Nuclear Medicine & Radio Pharmaceuticals Average Price by Players/Suppliers (2013-2018)

2.4 United States Nuclear Medicine & Radio Pharmaceuticals Market Competitive Situation and Trends

2.4.1 United States Nuclear Medicine & Radio Pharmaceuticals Market Concentration Rate

2.4.2 United States Nuclear Medicine & Radio Pharmaceuticals Market Share of Top 3 and Top 5 Players/Suppliers

2.4.3 Mergers & Acquisitions, Expansion in United States Market

2.5 United States Players/Suppliers Nuclear Medicine & Radio Pharmaceuticals Manufacturing Base Distribution, Sales Area, Product Type

 3 United States Nuclear Medicine & Radio Pharmaceuticals Sales (Volume) and Revenue (Value) by Region (2013-2018)

3.1 United States Nuclear Medicine & Radio Pharmaceuticals Sales and Market Share by Region (2013-2018)

3.2 United States Nuclear Medicine & Radio Pharmaceuticals Revenue and Market Share by Region (2013-2018)

3.3 United States Nuclear Medicine & Radio Pharmaceuticals Price by Region (2013-2018)

Continue....

 Who we are

Research Trades has team of experts who works on providing exhaustive analysis pertaining to market research on a global basis. This comprehensive analysis is obtained by a thorough research and study of the ongoing trends and provides predictive data regarding the future estimations, which can be utilized by various organizations for growth purposes.

We distribute customized reports that focus on meeting the client’s specific requirement. Our database consists of a large collection of high-quality reports obtained using a customer-centric approaches, thus providing valuable research insights.

Reach at us:

Email: sales@researchtrades.com                          

Call us: +1 6269994607 (USA), +91 7507349866 (IND)

Web: https://www.researchtrades.com

Skype ID: researchtradescon.

[marketresearchinsight-blog]

APAC Radiopharmaceuticals Market Outlook By 2024

The APAC Radiopharmaceuticals/Nuclear Medicine Market is expected to reach USD 2.9 billion by 2024, according to the new report by Grand View Research, Inc. Radiopharmaceuticals are widely used in the field of oncology, and cardiovascular diseases. Ongoing research and studies demonstrating positive results is widening the scope of radioisotope applications for the diagnosis and treatment of bone diseases, respiratory diseases, thyroid-related diseases, and conditions of the digestive tract. Along with these applications, the radioisotopes are largely used in radiopharmacology to study drug movement in lab subjects.

Gamma emitter Technetium-99m is the most commonly used radioisotope in radiopharmaceuticals. Other widely used radioisotopes include Fluorine-18, Indium-111, and Iodine-131. Numerous research studies are further expanding the application areas of radiopharmaceuticals in diagnostics as well as in therapeutics.

Adoption of PET as a diagnostic tool is rapidly increasing since it offers high accuracy over other diagnostic techniques. The accuracy in the diagnosis has a direct impact on decision-making and treatment monitoring process. PET is commonly integrated with X-ray and computed tomography to increase the accuracy. The growing demand for these diagnostic procedures is expected to fuel the market growth during the forecast period.

Currently available cancer treatment options, such as chemotherapy and radiation therapy, include drugs and radiations, which are non-target specific. Thus, these therapies have a major disadvantage of affecting the whole body or the organs surrounding the target site. Radioisotopes have an advantage over these techniques since they aid in targeting specifically the tumor without affecting the surrounding body parts. Thus, benefits associated with these diagnostic and treatment procedures is augmenting the demand for radiopharmaceuticals in disease treatment and diagnosis.

To request a sample copy or view summary of this report, click the link below: www.grandviewresearch.com/industry-analysis/asia-pacific-radiopharmaceuticals-market

Further key findings from the study suggest:

The buyers of radiopharmaceutical include hospitals, physicians, diagnostic laboratories, research institutes and others. Hospitals form the biggest buyer groups owing to their high patient turnover and greater financing capabilities.

Therapeutic products such as Alpha Emitters, Beta Emitters and Brachytherapy are anticipated to exhibit lucrative growth. Emergence of new treatment options for thyroid and other diseases is expected to support the growth over the forecast period.

The key diagnostic application areas of radiopharmaceuticals formed the largest market in 2015. These applications are in cardiology, neurology, oncology, and thyroid. Advent of accurate diagnostic methods and high burden of disorders supported the growth of this segment.

Thailand in South East Asia and China are expected to dominate the APAC radiopharmaceutical market. Efforts undertaken by the UN and other local healthcare authorities in this region are expected to result in installation of more PET and SPECT systems, thereby driving the demand.

Key players of the industry include Nordion, Inc., Bayer AG, Mallinckrodt Public Limited company, GE Healthcare, Bracco Imaging S.P.A and government initiatives such as Institute of Radioisotopes and The Australian Nuclear Science and Technology Organization (ANSTO)

Grand View Research has segmented the APAC radiopharmaceuticals market on the basis of product:

APAC Radiopharmaceuticals Product Outlook (Revenue, USD Million, 2013–2024)

Diagnostics

SPECT

TC-99m

TL-201

GA-67

I-123

Others

PET

F-18

RB-82

Others

Therapeutics

Alpha Emitters

RA-223

Beta Emitters

I-131

Y-90

SM-153

Re-186

Lu-117

Others

Brachytherapy

Cesium-131

Iodine-125

Palladium-103

Iridium-192

Others

Radiopharmaceuticals Regional Outlook (Revenue, USD Million, 2013–2024)

South East Asia

Indonesia

Thailand

Laos

Myanmar

Philippines

Malaysia

Vietnam

Cambodia

Rest of Asia Pacific

Japan

China

India

Browse Press Release of this Report: www.grandviewresearch.com/press-release/asia-pacific-radiopharmaceuticals-market-analysis

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

[insightslice]

Nuclear Medicine Market – Trends, Analysis and Forecasts 2020 – 2030

The nuclear medicine is an intricate branch of medical science that uses radiopharmaceuticals for detection and diagnostic procedures. The radiopharmaceuticals consist of radioisotopes produced through particle accelerator such as the medical cyclotron and are used for targeted therapy, detection based imaging and therapeutics. With advancement in medical technology, the imaging and diagnostic devices have evolved significantly. The nuclear medicines are used in the diagnostic imaging equipment to increase the efficacy of diagnosis and thus are gaining popularity worldwide. The radiopharmaceuticals are also used in the treatment of cancer, thyroid, bone metastasis, arthritis and so on, wherein doses of doses of ionizing radiation are delivered to diseases sites for curative or palliative applications. The nuclear medicines or radiopharmaceuticals are administered in very small quantities and thus does not possess any side effect. This has fueled the development of advanced radiopharmaceuticals and is anticipated to be a major factor driving the growth of the global nuclear medicine market during the forecast period.

North America contributed the largest share to the global nuclear medicine market in 2019 and is anticipated to be a dominating geography during the forecast period. The key factors driving the growth of nuclear medicine marker in North America are increasing investment in novel drug discovery, early adoption of nuclear medicine in therapeutic & diagnostic applications, and prevalence of chronic diseases primarily cancer & cardiovascular diseases. Asia Pacific contributed a significant share to the global nuclear medicine market in 2019 and is anticipated to be the fastest growing segment during the forecast period. Increasing investment in expansion of biotechnology and pharmaceutical industry, and rising adoption of advanced therapeutic and diagnostic technologies are expected to drive the Asia Pacific nuclear medicine market in coming years.

The report titled “Nuclear Medicine (Radiopharmaceuticals) Market – Global Market Share, Trends, Analysis and Forecasts, 2020-2030” offers market estimates for a period 2018 to 2030, wherein 2018 is historic period, 2019 is the base year, and 2020 to 2030 is forecast period. Additionally, the study takes into consideration the competitive landscape, wherein the report would provide company overview and market outlook for leading players in the global nuclear medicine market. Furthermore, the report would reflect the key developments, global & regional sales network, business strategies, research & development activities, employee strength, and key executive, for all the major players operating in the market. For instance, Bayer AG reported revenues of USD 46.8 billion in 2019 and the product segment analysis of the company indicates that Crop Science business segment of the company dominated revenue in 2019.

The global nuclear medicine (radiopharmaceuticals) market is segmented based on product type, applications, end user, and geography. Based on product type, the global nuclear medicine market is segmented into diagnostic nuclear medicine, therapeutic nuclear medicine, and brachytherapy isotopes. The diagnostic nuclear medicine is sub-segmented into single-photon emission computed tomography (SPECT) radiopharmaceuticals (Technetium-99m, Thallium-201, Gallium-67, Iodine-123, Other), and positron-emission tomography (PET) radiopharmaceuticals (F-18, Ru-82, Other). The therapeutic nuclear medicine is segmented into alpha emitters, and beta emitters (Iodine-131, Yttrium-90, Samarium-153, Lutetium-177, Rhenium-186, Other). The brachytherapy isotopes are sub-segmented into Iodine-125, Palladium-103, Cesium-131, Iridium-192, and other. Based on applications, the global nuclear medicine market is segmented into oncology, cardiology, neurology, thyroid, and others. Based on end user, the global nuclear medicine market is segmented into hospitals & diagnostic centers, and research institutes. Based on geography, the global nuclear medicine market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America.

Request PDF Sample: https://www.insightslice.com/request-sample/364

The research provides in-depth analysis of prominent players holding majority share of the global market with a focus on all operating business segment, and would identify the segment of the company focusing on Nuclear Medicine (Radiopharmaceuticals). Further, market share of prominent companies in the global Nuclear Medicine (Radiopharmaceuticals) market would also be estimated. For instance, Bayer AG operates through three business segments namely Crop Sciences, Pharmaceuticals, and Consumer Health. The nuclear medicines products are delivered under Pharmaceuticals business segment of the company with revenue contribution of US$ 19,337.1 million in 2019.

The study takes into consideration the key competitive information such as business strategy, product portfolio, key development, SWOT analysis, and research and development focus of all the nuclear medicine companies. The global nuclear medicine market study would take into consideration the participants engaged throughout the ecosystem of the market, along with their contribution. Product portfolio would focus on all the products under the nuclear medicine business segment of the company. Similarly, the recent development section would focus on the latest developments of company such as strategic alliances and partnerships, merger and acquisition, new product launched and geographic expansion in the global nuclear medicine market.

Get Discount On Report: https://www.insightslice.com/request-discount/364

Major players active in the global nuclear medicine market include Advanced Accelerator Applications, Bayer AG, Cardinal Health, Inc., Curium Pharma, Eczacıbaşı-Monrol, GE Healthcare, Lantheus Medical Imaging Inc., Nordion Inc., NTP Radioisotopes SOC Ltd, and The Bracco Group.

[megasddw-blog]

Radiopharmaceuticals Market Outlook and Forecast 2023: Growth Factors, Trends, and Top Companies Analysis for Business Development

MRFR is the Leading Brand in The Research Company who Recently Published Global Radiopharmaceuticals Market Research Reports which includes Study of Growth, Regional Overview, Top participants, Major Drivers and Forecast to 2023.

Radiopharmaceuticals Market - Overview

Global Radiopharmaceuticals Market to grow at a solid CAGR of 8.7% over the 2017-2023 forecast period due to the growing demand for radiopharmaceuticals in diagnostic as well as therapeutic applications in the healthcare sector.

As the healthcare industry is moving towards the personalized approaches, the role of radiopharmaceutical is also increasing. The radiopharmaceutical is acting as an all-rounder radiopharmaceutical from diagnosis to treatment for various chronic diseases such as cancers and other neurological disorders, which has provided an impetus to the market. Demand for radiopharmaceuticals is growing due to raising awareness about availability of radiation and radioisotopes in medicine, particularly for diagnosis and therapy for various chronic conditions. In developed countries about one person in 50 uses diagnostic nuclear medicine every year, and the demand for therapy with radioisotopes is about one-tenth of this. Radiopharmaceuticals use radiation to provide diagnostic information about the functioning of a person's specific organs while radiotherapy can be used to treat some medical conditions, especially cancer, used to weaken or destroy particular targeted cells.

Request Sample Copy at https://www.marketresearchfuture.com/sample_request/1650

Industry Updates:

In Q3 2018, Novartis (Advanced Accelerator Applications) acquired two new radioisotope drugs – Lu-PSMA-617 from Endocyte and FF-10158 from Fujifilm Toyama Chemical.

Competitive Players:

Leading players in the global radiopharmaceuticals market include Jubilant Life Sciences Ltd., Sun Pharmaceutical Industries Ltd., Cardinal Health Inc., GE Healthcare, Advanced Accelerator Applications SA (owned by Novartis), Nordion Inc., Bracco Diagnostic Inc., Avid Radiopharmaceuticals, IBA Dosimetry GmbH, Canadian Nuclear Laboratories, Mallinckrodt Pharmaceuticals, Lantheus Medical Imaging Inc., Medtronic, Bayer AG, and Siemens AG.

In a similar manner as X-rays, these radioisotopes help physicians diagnose a number of diseases. In contrast, radioisotopes that emit short-range particles such as alpha and beta particles are used in therapeutic applications, as short-range particles “burn up”, i.e. lose their energy, over relatively short distances, allowing spectacular results in terms of cell destruction on a highly local scale. Radioisotopes of the latter kind also stay for longer periods of time in the human body, allowing for prolonged treatment.

The growing prevalence of cancer is the primary driver for the global radiopharmaceuticals market, as cancer treatment accounts for the majority of the application of radiopharmaceuticals in the healthcare sector. Growing investment in cancer research in a number of countries round the world is likely to remain a major driver for the radiopharmaceuticals market over the forecast period, as many countries have started to take the threat of cancer seriously following a steady rise in the prevalence of many cancer types. On the other hand, the high cost of radiopharmaceuticals and the risks of using radiopharmaceuticals in therapeutic applications are likely to hamper the growth prospects of the global radiopharmaceuticals market over the forecast period.

Segmentation Analysis:

The global radiopharmaceutical market is segmented based on type, type of test, application, route of administration, end user, and region.

By type, the market for radiopharmaceuticals is segmented into diagnostic radiopharmaceuticals and therapeutic radiopharmaceuticals. The diagnostics segment is further sub-segmented into SPECT radiopharmaceuticals and PET radiopharmaceuticals; the SPECT radiopharmaceuticals segment is further sub-segmented into technetium-99m, thallium-201, iodine-123, and others, while The PET radiopharmaceuticals segment is further sub-segmented into F-18, rubidium-82, and others.

The therapeutic radiopharmaceuticals segment is further sub-segmented into beta emitters, alpha emitters, and brachytherapy. The beta emitters segment is further sub-segmented into iodine-131, yttrium-90, samarium-153, rhenium-186, lutetium-177, and others. The brachytherapy segment is sub-segmented into iodine-125, iridium-192, cesium-131, and others.

Browse Complete 271 Pages Premium Research Report Enabled with 30+ Respective Tables and Figures at https://www.marketresearchfuture.com/reports/radio-pharmaceutical-market-1650

By type of test, the market is segmented into myocardial perfusion scan, lung scan, bone scan, white blood cell scan, gallium scan, renal nuclear medicine scan, parathyroid scans, hepatobiliary scans, cerebral perfusion scan, and others. The myocardial perfusion scan segment is further sub-segmented into technetium-99m, thallium-201, rubidium-82, and others. The lung scan segment is further sub-segmented into xenon-133, krypton-81m, and others. The bone scan segment is further sub-segmented into technetium-99m, fluoride-18, and others. The white blood cell scan segment is sub-segmented into indium-111 and others.

By application, the market is segmented into oncology, cardiology, neurology, urology, and others. The oncology segment is further segmented into prostate cancer, bone cancer, breast cancer, and others. The cardiology segment is further segmented into coronary artery disease, cardiomyopathy, and others. The neurology segment is further segmented into traumatic brain injury, stroke, Alzheimer’s disease, and others. The urology segment is sub-segmented into acute pyelonephritis, congenital renal anomalies, and others.

By route of administration, the market is segmented into oral, intravenous, and others.

By end user, the market is segmented into hospitals, diagnostic centers, research institutes, and others.

Regional Analysis:

The global radiopharmaceuticals market is segmented by geography into the Americas, Europe, Asia Pacific, and the Middle East and Africa.

The Americas is the dominant regional segment of the global radiopharmaceuticals market and is likely to remain the leading contributor to the global market due to the high prevalence of cancer as well as other neurological and cardiovascular diseases in which radiopharmaceuticals are used in some capacity. The increasing investment in cancer research in the Americas, particularly the U.S., is likely to be a major driver for the radiopharmaceuticals market in the region over the forecast period.

Moreover, Asia Pacific is likely to be the fastest growing regional market due to the growing prevalence of cancer and the growing awareness about SPECT and PET systems.

Major TOC of Radiopharmaceutical Market Research Report – Forecast to 2023:

1   Report Prologue

2 Executive Summary

3 Market Introduction

4 Research Methodology

5 Market Dynamics

6 Market Factor Analysis

TOC CONTINUED…

List of Tables:

TABLE 1 MARKET SYNOPSIS 25

TABLE 2 GLOBAL RADIOPHARMACEUTICAL MARKET, BY TYPE, 2014–2023 (USD MILLION) 48

TABLE 3 GLOBAL RADIOPHARMACEUTICAL MARKET FOR DIAGNOSTIC, BY TYPE, 2014–2023 (USD MILLION) 49

TABLE 4 GLOBAL RADIOPHARMACEUTICAL MARKET FOR SPECT RADIOPHARMACEUTICALS, BY TYPE, 2014–2023 (USD MILLION) 49

TABLE 5 GLOBAL RADIOPHARMACEUTICAL MARKET FOR PET RADIOPHARMACEUTICALS, BY TYPE, 2014–2023 (USD MILLION) 50

TABLE 6 GLOBAL RADIOPHARMACEUTICAL MARKET FOR THERAPEUTIC, BY TYPE, 2014–2023 (USD MILLION) 50

TABLE 7 GLOBAL RADIOPHARMACEUTICAL MARKET FOR BETA EMITTERS, BY TYPE, 2014–2023 (USD MILLION) 50

TABLE 8 GLOBAL RADIOPHARMACEUTICAL MARKET FOR BRACHYTHERAPY, BY TYPE, 2014–2023 (USD MILLION) 51

TABLE 9 GLOBAL RADIOPHARMACEUTICAL MARKET FOR DIAGNOSTIC TYPE, BY REGION, 2014–2023 (USD MILLION) 51

TABLE 10 GLOBAL RADIOPHARMACEUTICAL MARKET FOR THERAPEUTIC TYPE, BY REGION, 2014–2023 (USD MILLION) 51

LOT CONTIONUED…!

To know more Updates Related Report Visit at https://www.openpr.com/news/1115880/Radiopharmaceutical-Market-2018-Renowned-Players-like-Siemens-Sun-Pharmaceutical-Industries-Cardinal-Health-Medtronic-etc-by-2023.html

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

[amanjadejablog]

Therapeutic Nuclear Medicines Market Forecast ‑ Industry Value, Size, Top Companies and Trends for 2019-2025

“The Therapeutic Nuclear Medicines market report is a complete research on the current state of the Therapeutic Nuclear Medicines market with a focus on the regional market. This report presents the global Therapeutic Nuclear Medicines market size (value, production, and consumption), splits the breakdown (data status 2013-2018 and forecast to ‘2025’), by manufacturers, region, type, and application. This study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter’s Five Forces Analysis.

This research is helpful for all the players operating in the market, including the well-established players and the new entrants. This intelligent study provides the definition, description, and the overall forecasts of the global market, considering the market segments and sub-segments, which includes the product types, technologies, end-users, industry verticals, and the key geographies. Moreover, the report also provides an in-depth analysis of some of the significant factors such as driving forces, challenges, and threats that will shape the future of the market. In addition, the report also includes the lucrative opportunities in the micro markets for all the participants to invest in the global Therapeutic Nuclear Medicines market. Besides, the report describes the product offerings and the competitive analysis of the major players operating in the market.

Get a FREE Sample PDF Report: https://www.marketgrowthinsight.com/sample/18805

The report also presents the market competitive landscape and a corresponding detailed analysis of the major vendor/key players in the market.

The key players covered in this report: 

• The major manufacturers covered in this report Cardinal Health Mallinckrodt GE Healthcare Lantheus Medical Imaging Bayer Bracco Imaging Eczacibasi-Monrol Nuclear Products Nordion Advanced Accelerator Applications IBA Molecular Imaging

• Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering North America Europe China Japan Southeast Asia India

• On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into Beta Emitters Alpha Emitters Brachytherapy Products

• On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including Thyroid Bone Metastasis Lymphoma Endocrine Tumors Others

• Key Stakeholders Therapeutic Nuclear Medicines Manufacturers Therapeutic Nuclear Medicines Distributors/Traders/Wholesalers Therapeutic Nuclear Medicines Subcomponent Manufacturers Industry Association Downstream Vendors

This report studies the global Therapeutic Nuclear Medicines market status and forecast, categorizes the global Therapeutic Nuclear Medicines market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia).

Get Discount on this Report: https://www.marketgrowthinsight.com/discount/18805

The prime objective of this Therapeutic Nuclear Medicines research report is to define the size of the different segments and the geographies as well as to forecast the trends that are likely to gain traction in the following couple of years. This market research report has been designed to incorporate both the qualitative and quantitative aspects of the industry within each of the regions.

The scope of this report centers on key market analyses, market drivers & challenges, and competitive analysis & trends. Research report examines each market and its applications, regulatory scenario, technological innovations, Therapeutic Nuclear Medicines market projections, market sizes, and shares. Moreover, the Therapeutic Nuclear Medicines market report examines the most recent trends, pipeline products and developments in the Therapeutic Nuclear Medicines market. Complete profiles of leading organizations in the market are also mentioned in this report.

Therapeutic Nuclear Medicines market report highlights: 1. The Therapeutic Nuclear Medicines research report provides a detailed survey of the current and future industry trends so as to identify the investment analysis. 2. The industry forecasts, using estimated market values have been mentioned, till ‘2025’. 3. The Therapeutic Nuclear Medicines Market dynamics such as the drivers, restraints, threats, opportunities, and industry-specific challenges 4. Key industry trends across all the market segments and sub-segments, geographies, and nations. 5. Key developments and strategies determined in the market. 6. Detailed profiling of the leading competitors and the entrant market players. 7. Growth prospects among the emerging nations throughout the forecast period. 8. The Therapeutic Nuclear Medicines Market opportunities and recommendations for new investments.

In the end, It includes the methodical description of the various factors such as the market growth and a detailed information about the different company’s revenue, growth, technological developments, production, and the various other strategic developments.

Purchase Therapeutic Nuclear Medicines Market Research Report: https://www.marketgrowthinsight.com/checkout/18805

Thus, the Therapeutic Nuclear Medicines Market Report serves as a valuable material for all industry competitors and individuals having a keen interest in Therapeutic Nuclear Medicines Market study.

About us : Market Growth Insight, is a one stop solution for market research reports in various business categories. We are serving 100+ clients with 10000+ diverse industry reports and our reports are developed to simplify strategic decision making, on the basis of comprehensive and in-depth significant information, established through wide ranging analysis and latest industry trends. Contact us : 502, Sai Radhe, Kenedy Road, Behind Hotel Sheraton Grand, Near Pune Station, Pune-411001, sales@marketgrowthinsight.com + 91 8956 049 020

Connect With Us : Twitter | Linkedin | Facebook | Google+

  from WordPress http://bit.ly/2Xmg0Pz via IFTTT

[crystalmarketresearch]

Radiopharmaceuticals Market Analysis and Opportunity Assessment with Emerging Trends, New Growth Opportunities, Competitive Landscape, Market Growth Status 2014-2023

A research study titled, “Radiopharmaceuticals Market by type, procedural volumes and application- global industry analysis and forecast to 2023”, published by crystal market research. Market Highlights: The global Radiopharmaceuticals market was worth USD 3.89 billion in 2014 and is expected to reach approximately USD 8.77 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 9.45% during the forecast period. The market is right now in its development phase driven by expanding number of disease cases and increasing awareness about nuclear medication. Radiopharmaceuticals are pharmaceutical formulations involving radioactive isotopes that are useful as a part of analysis and therapeutics. They are basic and small substances that contain a radioactive substance that is useful as a part of the treatment of cancer and neurological and cardiac disorders. The regular chemotherapy techniques are being supplanted by more advantageous helpful radiopharmaceuticals for oncology and cancer treatment, which opens up new roads in the radiopharmaceuticals market. Click To Request A Sample: https://www.crystalmarketresearch.com/report-sample/HC01517

Market Classification:

Radiopharmaceuticals Market, By Type, Estimates and Forecast, 2014-2023($Billion): Diagnostic Nuclear Medicine/Radiopharmaceuticals

SPECT Radiopharmaceuticals

PET Radiopharmaceuticals

Therapeutic Nuclear Medicine/Radiopharmaceuticals

Beta Emitters

Alpha Emitters

Brachytherapy

Radiopharmaceuticals Market, By Procedural Volumes, Estimates and Forecast, 2014-2023($Billion): Diagnostic Procedures

SPECT Radiopharmaceuticals

PET Radiopharmaceuticals

Therapeutic Procedures

Beta Emitters

Alpha Emitters

Brachytherapy

Radiopharmaceuticals Market, By Application, Estimates and Forecast, 2014-2023($Billion): Diagnostic Applications

SPECT

PET

Therapeutic Applications

Thyroid

Bone Metastasis

Lymphoma

Endocrine Tumors

Other Radiopharmaceuticals Market, By Region, Estimates and Forecast, 2014-2023($Billion): Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) North America (U.S, Canada, Mexico) Europe (Germany, France, UK, Italy, Spain, Rest of Europe) Asia-Pacific (Japan, China, Australia, India, South Korea, Rest of Asia-Pacific)

Rest of the World  (Brazil, South Africa, Saudi Arabia, Turkey, United Arab Emirates, Others)    Read Premium News from AB Newswire of  “Real-Time-Health-Monitoring-Devices-Market At: https://www.prnewswire.com/news-releases/real-time-health-monitoring-devices-market-2018-scope--by-type-wearable-devices--home-health-medical-devices--technological-innovation-in-healthcare-for-better-lifestyle--global-forecasts-up-to-2023-683445551.html

Competitive Insights: The leading players in the market are Bracco Imaging S.p.A, IBA Molecular Imaging India Private Limited, Wipro GE Healthcare Pvt Ltd, Bayer HealthCare Pharmaceuticals LLC, Nordion Inc, Lantheus Medical Imaging Inc, Cardinal Health, Advanced Accelerator Applications and Mallinckrodt. Regional Outlook and Trend Analysis: Geographically, the market is fragmented into Europe, North America, Asia-Pacific, and the Rest of the World.  North America is accounted for the biggest share, trailed by Asia-Pacific and Europe In 2016. The Asia-Pacific locale is foreseen to develop at the most elevated CAGR amid the estimate time frame. This high development can be ascribed to the establishment of PET scanners in India and activities by the legislature of the Asian nations to advance health among others. Research Methodology:

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments. Check discount offer for Report click on the link @ https://www.crystalmarketresearch.com/check-discount/HC01517

About Crystal Market Research: Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy. Contact Us: Judy S, 304 South Jones Blvd, Suite 1896, Las Vegas NV 89107, United States Toll Free: +1-888-213-4282 Email: sales@crystalmarketresearch.com